Literature DB >> 5017315

Serum transaminases and salicylate therapy.

T Iancu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5017315      PMCID: PMC1787971          DOI: 10.1136/bmj.2.5806.167

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  The influence of rheumatic fever on serum concentrations of the enzyme, glutamic oxalacetic transaminase.

Authors:  I NYDICK; J TANG; G H STOLLERMAN; F WROBLEWSKI; J S LADUE
Journal:  Circulation       Date:  1955-11       Impact factor: 29.690

2.  Hepatic involvement in juvenile rheumatoid arthritis.

Authors:  J Schaller; B Beckwith; R J Wedgwood
Journal:  J Pediatr       Date:  1970-08       Impact factor: 4.406

3.  Serum transaminases during salicylate therapy.

Authors:  A S Russell; R A Sturge; M A Smith
Journal:  Br Med J       Date:  1971-05-22
  3 in total
  5 in total

1.  Liver injury by salicylates.

Authors:  T Iancu
Journal:  Br Med J       Date:  1973-09-01

2.  Analgesic hepatotoxicity.

Authors:  R R Babb
Journal:  West J Med       Date:  1978-08

3.  Cholestatic jaundice caused by D-penicillamine.

Authors:  D Barzilai; G Dickstein; R Enat; H Bassan; C Lichtig; B Gellei
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

4.  Aspirin-induced hepatic dysfunction in a patient with adult rheumatoid arthritis.

Authors:  D A Saltzman; E P Gall; S F Robinson
Journal:  Am J Dig Dis       Date:  1976-09

Review 5.  Rheumatoid arthritis and liver involvement.

Authors:  S Sullivan; E B Hamilton; R Williams
Journal:  J R Coll Physicians Lond       Date:  1978-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.